173 related articles for article (PubMed ID: 26095814)
1. Autologous iPSC-derived dopamine neuron grafts show considerable promise in a nonhuman primate model of Parkinson's disease.
Wakeman DR
Mov Disord; 2015 Jul; 30(8):1034. PubMed ID: 26095814
[No Abstract] [Full Text] [Related]
2. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
[TBL] [Abstract][Full Text] [Related]
3. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1.
Samata B; Doi D; Nishimura K; Kikuchi T; Watanabe A; Sakamoto Y; Kakuta J; Ono Y; Takahashi J
Nat Commun; 2016 Oct; 7():13097. PubMed ID: 27739432
[TBL] [Abstract][Full Text] [Related]
4. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
[TBL] [Abstract][Full Text] [Related]
5. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
[TBL] [Abstract][Full Text] [Related]
6. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
[TBL] [Abstract][Full Text] [Related]
7. Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
Arenas E
J Mol Cell Biol; 2014 Feb; 6(1):42-53. PubMed ID: 24431302
[TBL] [Abstract][Full Text] [Related]
8. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease.
Kikuchi T; Morizane A; Doi D; Onoe H; Hayashi T; Kawasaki T; Saiki H; Miyamoto S; Takahashi J
J Parkinsons Dis; 2011; 1(4):395-412. PubMed ID: 23933658
[TBL] [Abstract][Full Text] [Related]
9. Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations.
Zhong P; Hu Z; Jiang H; Yan Z; Feng J
Cell Rep; 2017 May; 19(5):1033-1044. PubMed ID: 28467897
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease.
Cardo LF; Monzón-Sandoval J; Li Z; Webber C; Li M
Cells; 2023 Dec; 12(24):. PubMed ID: 38132179
[TBL] [Abstract][Full Text] [Related]
11. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
12. Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.
Schwab AJ; Sison SL; Meade MR; Broniowska KA; Corbett JA; Ebert AD
Stem Cell Reports; 2017 Dec; 9(6):1839-1852. PubMed ID: 29129681
[TBL] [Abstract][Full Text] [Related]
13. Decoding Parkinson's disease - iPSC-derived models in the OMICs era.
Krach F; Bogiongko ME; Winner B
Mol Cell Neurosci; 2020 Jul; 106():103501. PubMed ID: 32439399
[TBL] [Abstract][Full Text] [Related]
14. Towards stem cell based therapies for Parkinson's disease.
Parmar M
Development; 2018 Jan; 145(1):. PubMed ID: 29311261
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
16. Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors.
Nishimura K; Murayama S; Takahashi J
Stem Cells Transl Med; 2015 Aug; 4(8):932-44. PubMed ID: 26041738
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease.
Doi D; Magotani H; Kikuchi T; Ikeda M; Hiramatsu S; Yoshida K; Amano N; Nomura M; Umekage M; Morizane A; Takahashi J
Nat Commun; 2020 Jul; 11(1):3369. PubMed ID: 32632153
[TBL] [Abstract][Full Text] [Related]
18. iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.
Laperle AH; Sances S; Yucer N; Dardov VJ; Garcia VJ; Ho R; Fulton AN; Jones MR; Roxas KM; Avalos P; West D; Banuelos MG; Shu Z; Murali R; Maidment NT; Van Eyk JE; Tagliati M; Svendsen CN
Nat Med; 2020 Feb; 26(2):289-299. PubMed ID: 31988461
[TBL] [Abstract][Full Text] [Related]
19. Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel.
Comini G; Kelly R; Jarrin S; Patton T; Narasimhan K; Pandit A; Drummond N; Kunath T; Dowd E
J Neural Eng; 2024 Mar; 21(2):. PubMed ID: 38479026
[No Abstract] [Full Text] [Related]
20. Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson's Disease.
Samson JS; Ramesh A; Parvathi VD
Neuroscience; 2024 May; 546():1-19. PubMed ID: 38522661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
